繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Coeptis Therapeutics宣布反向股票拆分

2024-12-27 21:51

  • Coeptis Therapeutics (NASDAQ:COEP) on Friday said it will proceed with a 1-for-20 reverse stock split of its issued and outstanding shares of common stock.
  • The first day of trading on a post-split basis on Nasdaq will be on December 31, 2024.
  • The company said the reverse split is intended to help meet the minimum bid price requirement necessary to maintain its listing on Nasdaq.
  • COEP -26.44% premarket to $0.1552.
  • Source: Press Release

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。